posted on 2024-02-02, 05:02authored byRebecca J Mitchell, Geoffrey P Delaney, Gaston Arnolda, Winston Liauw, Jane L Phillips, Reidar P Lystad, Reema Harrison, Jeffrey Braithwaite
Supplementary Material 1: Table S1: Identification of cancer type. Table S2: Demographic characteristics of the cancer decedents by potentially burdensome ED and hospital admission care indicators. Table S3: Cancer and clinical characteristics of the cancer decedents by potentially burdensome ED and hospital admission care indicators. Table S4: Demographic characteristics of the cancer decedents by potentially burdensome chemotherapy or radiotherapy indicators during 2016-2019. Table S5: Cancer and clinical characteristics of the cancer decedents by potentially burdensome chemotherapy or radiotherapy indicators during 2016-2019. Figure S1a: Predictors of characteristics associated with potentially burdensome care at the end of life by indicator type, 2014-2019. Figure S1b: Predictors of characteristics associated with potentially burdensome care at the end of life by indicator type, 2014-2019. Figure S2: Mean number of hospital admissions (a) and ED presentations (b) by month in the last 12 months of life, 2014-2019. Figure S3: Mean number of non-admitted patient occasions of service1 by month in the last 12 months of life, 2016-2019
Funding
NHMRC Centre of Research Excellence in Implementation Science in Oncology